Tigermed Completes Share Transfer of Teddy Clinical Laboratory to Frontage Laboratories for RMB 270 Million
China‑based Hangzhou Tigermed Consulting Co., Ltd. (HKG: 3347) announced that it and its subsidiary Jiaxing...
HKG: 3347
Tigermed Partners with Africare BioPharma to Enhance Africa’s Clinical Research Capabilities
On August 8, 2025, Hangzhou Tigermed Consulting (SHE: 300347, HKG: 3347), a China-based contract research...
Tigermed Acquires Japan’s Micron CRO to Expand Imaging Expertise in Asia-Pacific
China-based Tigermed (SHE: 300347, HKG: 3347) announced on July 29, 2025, that it has completed...
Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million
Tigermed (SHE: 300347, HKG: 3347) has announced its intention to acquire a 40.5650% stake in...
Tigermed Partners with Beijing Government to Open North Headquarters, Expanding Collaboration in Biotech
Tigermed, a prominent Contract Research Organization (CRO) with a presence in both Shenzhen (SHE: 300347)...
Tigermed Expands Asia Pacific Presence with Acquisition of Japanese CRO Medical Edge
Tigermed (SHE: 300347, HKG: 3347), a leading China-based Contract Research Organization (CRO), has announced the...
China’s Tigermed Taps Veeva Systems for Advanced Electronic Data Acquisition
Veeva Systems, a U.S.-based life science cloud software specialist, has entered into a partnership with...
Tigermed Establishes International Headquarters in Hong Kong to Accelerate Global Expansion
China-based Contract Research Organization (CRO) Tigermed (SHE: 300347, HKG: 3347) has announced the opening of...
Teddy Clinical Research Lab Partners with Cerba Research for Global Services
China-based Teddy Clinical Research Laboratory Limited, a joint venture (JV) between Dian Diagnostics (SHE: 300244)...
Tigermed Completes Acquisition of Croatia-Based CRO Marti Farm
China-based Contract Research Organization (CRO) Tigermed (SHE: 300347, HKG: 3347) has announced the completion of...